Skip to main content
Erschienen in: Pediatric Nephrology 9/2012

01.09.2012 | Original Article

C1GALT1 polymorphisms are associated with Henoch–Schönlein purpura nephritis

verfasst von: Xuelian He, Peiwei Zhao, Shixiu Kang, Yan Ding, Jiangwei Luan, Zhisheng Liu, Yanxiang Wu, Wei Yin

Erschienen in: Pediatric Nephrology | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Henoch–Schönlein purpura nephritis (HSPN) is the most serious long-term complication of Henoch–Schönlein purpura and aberrant galactosylation of IgA1 plays a role in its development. However, the precise role of genetic factors contributing to the abnormal IgA1 galactosylation remains unknown.

Methods

In order to examine the effects of C1GALT1 gene encoding core 1 β1,3-galactosyltransferase, an important role in the β1,3 glycosylation of IgA1, on HSPN susceptibility, we conducted a case–control association genetic study in 269 HSP and 61 HSPN in China. Five tagging SNPs, SNP1(-734 C/T), SNP4(-465A/G), SNP6(-330 G/T), SNP7(-292 C/-), and SNP8(1365 G/A) in C1GALT1 were studied using single-locus and haplotype-based multilocus analysis.

Results

Our results demonstrated that 1365 G allele frequency was significantly higher in HSPN patients than in HSP patients without nephritis (0.459 vs 0.331, p = 0.0008, adjusted p’ = 0.004) with an odds ratio (OR) = 1.716, 95%CI 1.151–2.560). The GG genotype of 1,365 G/A was significantly different in HSP without nephritis and HSPN (p = 0.008, adjusted p’’ = 0.04). We did not observe statistically significant differences in haplotype frequencies between HSPN and HSP patients.

Conclusions

In conclusion, our study suggested that the 1365 G/A polymorphism of the C1GALT1 gene may contribute to HSPN development.
Literatur
1.
Zurück zum Zitat García-Porrúa C, Calviño MC, Llorca J, Couselo JM, González-Gay MA (2002) Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 32:149–156PubMedCrossRef García-Porrúa C, Calviño MC, Llorca J, Couselo JM, González-Gay MA (2002) Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 32:149–156PubMedCrossRef
2.
3.
Zurück zum Zitat Lau KK, Suzuki H, Novak J, Wyatt RJ (2010) Pathogenesis of Henoch-Schönlein purpura nephritis. Pediatr Nephrol 25:19–26PubMedCrossRef Lau KK, Suzuki H, Novak J, Wyatt RJ (2010) Pathogenesis of Henoch-Schönlein purpura nephritis. Pediatr Nephrol 25:19–26PubMedCrossRef
4.
Zurück zum Zitat Waldo FB (1998) Is Henoch-Schönlein purpura the systemic form of IgA nephropathy? Am J Kidney Dis 12:373–377 Waldo FB (1998) Is Henoch-Schönlein purpura the systemic form of IgA nephropathy? Am J Kidney Dis 12:373–377
5.
Zurück zum Zitat He X, Lu H, Kang S, Luan J, Liu Z, Yin W, Yao H, Ding Y, Li T, Heng CK (2010) MEFV E148Q polymorphism is associated with Henoch-Schönlein purpura in Chinese children. Pediatr Nephrol 25:2077–2082PubMedCrossRef He X, Lu H, Kang S, Luan J, Liu Z, Yin W, Yao H, Ding Y, Li T, Heng CK (2010) MEFV E148Q polymorphism is associated with Henoch-Schönlein purpura in Chinese children. Pediatr Nephrol 25:2077–2082PubMedCrossRef
6.
Zurück zum Zitat Mestecky J, Novak J, Julian BA (2002) Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19:1008–1014 Mestecky J, Novak J, Julian BA (2002) Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19:1008–1014
7.
Zurück zum Zitat Allen AC, Harper SJ, Feehally J (1995) Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 100:470–474PubMedCrossRef Allen AC, Harper SJ, Feehally J (1995) Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 100:470–474PubMedCrossRef
8.
Zurück zum Zitat Tomana M, Matousovic K, Julian BA, Radl J, KonecnyK MJ (1997) Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 52:509–516PubMedCrossRef Tomana M, Matousovic K, Julian BA, Radl J, KonecnyK MJ (1997) Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 52:509–516PubMedCrossRef
9.
Zurück zum Zitat Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J (2007) Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol 22:2067–2072PubMedCrossRef Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J (2007) Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol 22:2067–2072PubMedCrossRef
10.
Zurück zum Zitat Allen AC, Willis FR, Beattie TJ, Feehally J (1998) Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 13:930–934PubMedCrossRef Allen AC, Willis FR, Beattie TJ, Feehally J (1998) Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 13:930–934PubMedCrossRef
11.
Zurück zum Zitat Julian BA, Novak J (2004) IgA nephropathy: an update. Curr Opin Nephrol Hypertens 13:171–179PubMedCrossRef Julian BA, Novak J (2004) IgA nephropathy: an update. Curr Opin Nephrol Hypertens 13:171–179PubMedCrossRef
12.
Zurück zum Zitat Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104:73–81PubMedCrossRef Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104:73–81PubMedCrossRef
13.
Zurück zum Zitat Kokubo T, Hiki Y, Iwase H, Tanaka A, Toma K, Hotta K, Kobayashi Y (1998) Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 9:2048–2054PubMed Kokubo T, Hiki Y, Iwase H, Tanaka A, Toma K, Hotta K, Kobayashi Y (1998) Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 9:2048–2054PubMed
14.
Zurück zum Zitat Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY (2004) Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol 136:168–175PubMedCrossRef Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY (2004) Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol 136:168–175PubMedCrossRef
15.
Zurück zum Zitat Ju T, Cummings RD (2002) A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci U S A 99:16613–16618PubMedCrossRef Ju T, Cummings RD (2002) A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci U S A 99:16613–16618PubMedCrossRef
16.
Zurück zum Zitat Ju T, Cummings RD (2005) Protein glycosylation: chaperone mutation in Tn syndrome. Nature 437:1252PubMedCrossRef Ju T, Cummings RD (2005) Protein glycosylation: chaperone mutation in Tn syndrome. Nature 437:1252PubMedCrossRef
17.
Zurück zum Zitat Li GS, Zhang H, Lv JC, Shen Y, Wang HY (2007) Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int 71:448–453PubMedCrossRef Li GS, Zhang H, Lv JC, Shen Y, Wang HY (2007) Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int 71:448–453PubMedCrossRef
18.
Zurück zum Zitat Pirulli D, Crovella S, Ulivi S, Zadro C, Bertok S, Rendine S, Scolari F, Foramitti M, Ravani P, Roccatello D, Savoldi S, Cerullo G, Lanzilotta SG, Bisceglia L, Zelante L, Floege J, Alexopoulos E, Kirmizis D, Ghiggeri GM, Frascà G, Schena FP, Amoroso A, European IgAN Consortium (2009) European IgAN Consortium. Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy. J Nephrol 22:152–159PubMed Pirulli D, Crovella S, Ulivi S, Zadro C, Bertok S, Rendine S, Scolari F, Foramitti M, Ravani P, Roccatello D, Savoldi S, Cerullo G, Lanzilotta SG, Bisceglia L, Zelante L, Floege J, Alexopoulos E, Kirmizis D, Ghiggeri GM, Frascà G, Schena FP, Amoroso A, European IgAN Consortium (2009) European IgAN Consortium. Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy. J Nephrol 22:152–159PubMed
19.
Zurück zum Zitat Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936–941PubMedCrossRef Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936–941PubMedCrossRef
20.
Zurück zum Zitat Shi YY, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15:97–98PubMedCrossRef Shi YY, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15:97–98PubMedCrossRef
21.
Zurück zum Zitat Amoli MM, Thomson W, Hajeer AH, Calviño MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) HLA-B35 association with nephritis in Henoch-Schönlein purpura. J Rheumatol 29:948–949PubMed Amoli MM, Thomson W, Hajeer AH, Calviño MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) HLA-B35 association with nephritis in Henoch-Schönlein purpura. J Rheumatol 29:948–949PubMed
22.
Zurück zum Zitat Yoshioka T, Xu YX, Yoshida H, Shiraga H, Muraki T, Ito K (1998) Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis. Arch Dis Child 79:394–399PubMedCrossRef Yoshioka T, Xu YX, Yoshida H, Shiraga H, Muraki T, Ito K (1998) Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis. Arch Dis Child 79:394–399PubMedCrossRef
23.
Zurück zum Zitat Zhou J, Tian X, Xu Q (2004) Angiotensin-converting enzyme gene insertion/deletion polymorphism in children with Henoch-Schonlein purpura nephritis. Huazhong Univ Sci Technolog Med Sci 24:158–161CrossRef Zhou J, Tian X, Xu Q (2004) Angiotensin-converting enzyme gene insertion/deletion polymorphism in children with Henoch-Schonlein purpura nephritis. Huazhong Univ Sci Technolog Med Sci 24:158–161CrossRef
24.
Zurück zum Zitat Liu D, Lu F, Zhai S, Wei L, Ma S, Chen X, Dong L, Guo Y, Wu J, Wang Z (2010) Renin-angiotensin system gene polymorphisms in children with Henoch-Schonlein purpura in West China. J Renin Angiotensin Aldosterone Syst 11:248–255CrossRef Liu D, Lu F, Zhai S, Wei L, Ma S, Chen X, Dong L, Guo Y, Wu J, Wang Z (2010) Renin-angiotensin system gene polymorphisms in children with Henoch-Schonlein purpura in West China. J Renin Angiotensin Aldosterone Syst 11:248–255CrossRef
25.
Zurück zum Zitat Amoroso A, Danek G, Vatta S, Crovella S, Berrino M, Guarrera S, Fasano ME, Mazzola G, Amore A, Gianoglio B, Peruzzi L, Coppo R (1998) Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schoenlein patients. Italian Group of Renal Immunopathology. Nephrol Dial Transplant 13:3184–83188PubMedCrossRef Amoroso A, Danek G, Vatta S, Crovella S, Berrino M, Guarrera S, Fasano ME, Mazzola G, Amore A, Gianoglio B, Peruzzi L, Coppo R (1998) Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schoenlein patients. Italian Group of Renal Immunopathology. Nephrol Dial Transplant 13:3184–83188PubMedCrossRef
26.
Zurück zum Zitat Rueda B, Perez-Armengol C, Lopez-Lopez S, Garcia-Porrua C, Martín J, Gonzalez-Gay MA (2006) Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schönlein purpura. J Rheumatol 33:69–73PubMed Rueda B, Perez-Armengol C, Lopez-Lopez S, Garcia-Porrua C, Martín J, Gonzalez-Gay MA (2006) Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schönlein purpura. J Rheumatol 33:69–73PubMed
27.
Zurück zum Zitat Amoli MM, Thomson W, Hajeer AH, Calviño MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2001) HLA-DRB1*01 association with Henoch-Schönlein purpura in patients from northwest Spain. J Rheumatol 28:1266–1270PubMed Amoli MM, Thomson W, Hajeer AH, Calviño MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2001) HLA-DRB1*01 association with Henoch-Schönlein purpura in patients from northwest Spain. J Rheumatol 28:1266–1270PubMed
28.
Zurück zum Zitat Martin J, Paco L, Ruiz MP, Lopez-Nevot MA, Garcia-Porrua C, Amoli MM, Calviño MC, Ollier WE, Gonzalez-Gay MA (2005) Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain. J Rheumatol 32:1081–1085PubMed Martin J, Paco L, Ruiz MP, Lopez-Nevot MA, Garcia-Porrua C, Amoli MM, Calviño MC, Ollier WE, Gonzalez-Gay MA (2005) Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain. J Rheumatol 32:1081–1085PubMed
29.
Zurück zum Zitat Kiryluk K, Moldoveanu Z, Sanders JT, Eison TM, Suzuki H, Julian BA, Novak J, Gharavi AG, Wyatt RJ (2011) Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int 80:79–87PubMedCrossRef Kiryluk K, Moldoveanu Z, Sanders JT, Eison TM, Suzuki H, Julian BA, Novak J, Gharavi AG, Wyatt RJ (2011) Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int 80:79–87PubMedCrossRef
30.
Zurück zum Zitat Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, Lifton RP, Mestecky J, Novak J, Julian BA (2008) Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19:1008–1014PubMedCrossRef Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, Lifton RP, Mestecky J, Novak J, Julian BA (2008) Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19:1008–1014PubMedCrossRef
31.
Zurück zum Zitat Boyd JK, Barratt J (2011) Inherited IgA glycosylation pattern in IgA nephropathy and HSP nephritis: where do we go next? Kidney Int 80:8–10PubMedCrossRef Boyd JK, Barratt J (2011) Inherited IgA glycosylation pattern in IgA nephropathy and HSP nephritis: where do we go next? Kidney Int 80:8–10PubMedCrossRef
Metadaten
Titel
C1GALT1 polymorphisms are associated with Henoch–Schönlein purpura nephritis
verfasst von
Xuelian He
Peiwei Zhao
Shixiu Kang
Yan Ding
Jiangwei Luan
Zhisheng Liu
Yanxiang Wu
Wei Yin
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 9/2012
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-012-2178-9

Weitere Artikel der Ausgabe 9/2012

Pediatric Nephrology 9/2012 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.